Edgar Lomax CO Amgen Inc Transaction History

Edgar Lomax CO

$1.62 Billion
Q1 2024

A detailed history of Edgar Lomax CO transactions in Amgen Inc stock. As of the latest transaction made, Edgar Lomax CO holds 148,600 shares of AMGN stock, worth $46.4 Million. This represents 2.61% of its overall portfolio holdings.

Number of Shares

148,600

Previous 226,011 34.25%

Holding current value

$46.4 Million

Previous $65.1 Million 35.1%

% of portfolio

2.61%

Previous 4.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $20.8 Million - $25.1 Million	-77,411 Reduced 34.25%	148,600 $42.2 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $2.4 Million - $2.7 Million	-9,375 Reduced 3.98%	226,011 $65.1 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $1.88 Million - $2.34 Million	-8,605 Reduced 3.53%	235,386 $63.3 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $725,089 - $857,404	-3,384 Reduced 1.37%	243,991 $54.2 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $6.65 Million - $8.1 Million	29,435 Added 13.51%	247,375 $59.8 Million

Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $272,545 - $346,301	-1,190 Reduced 0.54%	217,940 $57.2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $524,114 - $591,105	-2,335 Reduced 1.05%	219,130 $49.4 Million
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $1.37 Million - $1.52 Million	5,920 Added 2.75%	221,465 $53.9 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $16.6 Million - $18.4 Million	75,885 Added 54.34%	215,545 $52.1 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $250,588 - $286,776	-1,260 Reduced 0.89%	139,660 $31.4 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $291,871 - $341,962	-1,375 Reduced 0.97%	140,920 $30 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $1.61 Million - $1.78 Million	-6,875 Reduced 4.61%	142,295 $34.7 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $33.1 Million - $38.6 Million	149,170 New	149,170 $37.1 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $14.8 Million - $16.7 Million	-81,778 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $267,600 - $312,375	-1,500 Reduced 1.8%	81,778 $15.9 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $537,341 - $605,781	-2,900 Reduced 3.37%	83,278 $17.3 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $116,235 - $130,557	700 Added 0.82%	86,178 $15.9 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $4.68 Million - $5.47 Million	27,625 Added 47.75%	85,478 $14.6 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $286,943 - $320,603	-1,700 Reduced 2.85%	57,853 $10.1 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $9.96 Million - $11.4 Million	59,553	59,553 $11.1 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.

Account